Alzheimer's disease diagnostic criteria
|
Alzheimer's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Alzheimer's disease diagnostic criteria On the Web |
|
American Roentgen Ray Society Images of Alzheimer's disease diagnostic criteria |
|
Risk calculators and risk factors for Alzheimer's disease diagnostic criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]
Diagnostic Criteria
The diagnosis of Alzheimer's disease can be made either on the basis of:
- National Institute on Aging and the Alzheimer's Association (NIA-AA); most recently updated in 2011, or
- DSM-V (Diagnostic and Statistical Manual of Mental Disorders, fifth edition) diagnostic criteria for major or mild neurocognitive disorder due to Alzheimer’s disease[1]
National Institute on Aging and the Alzheimer's Association (NIA-AA) describes Alzheimer's disease as:
- A decline from a previous level of functioning with inability or interference in carrying out usual daily activities.
- Loss of two or more cognitive abilities such as anterograde amnesia, aphasia, apraxia, agnosia, or other disturbance in executive functioning.
- Cognitive loss documented by mental status examination (MSE) or neuropsychological tests.
- Symptoms not consistent with other cerebrovascular disease, psychiatric disorders or delirium.
- Insidious onset and gradual progression of symptoms.
- Intact Consciousness
The The NIA-AA criteria differ from prior DSM criteria in the following way:
- NIA-AA recommends the use of biomarkers (such as Aβ and total and phosphorylated Tau protein) for early diagnosis of Alzheimer's disease in asymptomatic patients.
- NIA-AA defines three distinct stages of Alzheimer's disease:
- Preclinical Alzheimer's disease: No symptoms but measurable biologic evidence of Alzheimer's disease pathology.
- Mild cognitive impairment (MCI): Mild memory loss but no functional impairment.
- Alzheimer's disease leading to dementia.
The DSM-V diagnostic criteria for major or mild neurocognitive disorder due to Alzheimer’s disease includes: A. The criteria are met for major or mild neurocognitive disorder. B. There is insidious onset and gradual progression of impairment in one or more cognitive domains (for major neurocognitive disorder, at least two domains must be impaired). C. Criteria are met for either probable or possible Alzheimer’s disease as follows:
For major neurocognitive disorder:
Probable Alzheimer's disease is also known as major neurocognitive disorder. Major neurocognitive disorder due to Alzheimer's disease is diagnosed if either of the following is present; otherwise, possible Alzheimer’s disease should be diagnosed.
- Evidence of a causative Alzheimer’s disease genetic mutation from family history or genetic testing.
- All three of the following are present:
- Clear evidence of decline in memory and learning and at least one other cognitive domain (language, executive function, complex attention, perceptual-motor, and social cognition).
- Steadily progressive and gradual decline in cognition.
- No evidence of mixed etiology such as neurodegenerative or cerebrovascular disease, systemic disease or mental illness that can contribute to cognitive decline
For mild neurocognitive disorder:=
'Probable Alzheimer’s disease' is diagnosed if there is evidence of a causative Alzheimer’s disease genetic mutation from either genetic testing or family history. Possible Alzheimer’s disease is diagnosed if there is no evidence of a causative Alzheimer’s disease genetic mutation from either genetic testing or family history, and all three of the following are present:
1.Clear evidence of decline in memory and learning.
2.Steadily progressive, gradual decline in cognition, without extended plateaus.
3.No evidence of mixed etiology (i.e., absence of other neurodegenerative or cerebrovascular disease, or another neurological or systemic disease or condition likely contributing to cognitive decline).
AND
D.The disturbance is not better explained by cerebrovascular disease, another neurodegenerative disease, the effects of a substance, or another mental, neurological, or systemic disorder.
References
- ↑ Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.